Pigmentation Disorder Treatment Market

Pigmentation Disorder Treatment Market Size by Disorder Type (Vitiligo, Melasma and Others), Treatment (Corticosteroids, Calcineurin Inhibitor, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2024 to 2033

Base Year: 2023 Historical Data: 2020-22
  • Report ID: TBI-14225
  • Published Date: Mar, 2024
  • Pages: 236
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global pigmentation disorder treatment market was valued at USD 7 billion in 2023 and grew at a CAGR of 5% from 2024 to 2033. The market is expected to reach USD 11.40 billion by 2033. The rising awareness among the populace will drive the growth of the global pigmentation disorder treatment market.

Market Introduction:

Pigmentation disorders include a range of conditions where the skin loses its natural colour or develops irregular patches of darker or lighter pigmentation. These disorders can significantly impact one's appearance and self-esteem. Common types include hyperpigmentation, characterized by dark spots or patches due to excess melanin production, and hypopigmentation, marked by lighter areas of skin due to reduced melanin production. Topical treatments such as creams containing ingredients like hydroquinone or retinoids can help lighten dark spots and even skin tone. Chemical peels, involving the application of a chemical solution to exfoliate the skin, and laser therapy, which targets and breaks down excess pigment, are also common approaches. Other treatments include microdermabrasion, cryotherapy, and surgical procedures like skin grafting. Pigmentation disorder treatments improve the appearance of the skin and enhance individuals' self-confidence and quality of life. These treatments are cosmetic and contribute to overall well-being by addressing psychological distress associated with skin conditions and reducing the risk of sun damage and skin cancer in affected areas.

Pigmentation Disorder Treatment Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • The phase 1 clinical trials of Ahammune Biosciences, a startup located in Pune, have concluded for AB1001, an experimental novel medication being developed as a topical therapy for vitiligo.   Ahammune is the site of the discovery and development of AB1001, a novel class of chemicals with the potential to reverse pigmentation loss and slow disease progression. The molecule's Phase 1 trial has been completed, bringing a much-needed medication closer to the sufferers. Ahammune Biosciences and Ahmedabad-based Veeda Clinical Research collaborated on Ahammune's experimental novel medication, AB1001, for the first human trials.

Market Dynamics:

Drivers

The rising awareness about pigmentation disorders and their treatments - The rising accessibility of information through various channels, including online resources, has raised awareness about pigmentation disorders such as hyperpigmentation and vitiligo. As individuals become more informed about these conditions, they are more likely to seek professional advice and treatment options to address their specific concerns. The growing influence of social media platforms plays a significant role in shaping beauty standards and influencing consumer behaviour. Celebrities, beauty influencers, and skincare experts share their skincare routines and treatment experiences on social media, increasing interest in pigmentation disorder treatments. Therefore, the increasing awareness about pigmentation disorders and treatment options will drive the market's growth.

Restraints:

The cost of pigmentation disorder treatments The cost of pigmentation disorder treatments depends on various factors, including the type of treatment, the number of sessions required, the professional fees of the healthcare provider, and other relevant factors. Treatments range from topical creams and lotions to laser therapy and surgical interventions. The complexity and invasiveness of the treatment often correlate with higher costs. Multiple treatment sessions lead to the cumulative cost going up, making treatment expenses high and unaffordable for the majority of the patients. Dermatologists may have different fee structures, with more specialized providers often charging higher fees. Insurance coverage for pigmentation disorder treatments may not be available everywhere. Therefore, the cost considerations will render high-end services inaccessible to most of the population, given the high costs of these treatments, which will restrict the market's growth.

Opportunities:

Advancements and innovations in pigmentation disorder treatments - As awareness about pigmentation disorders continues to grow, individuals are seeking professional help to address their specific concerns, and this offers an incentive for stakeholders to invest capital in research and development to facilitate the creation of more effective treatment options. Advancements in treatment options, such as topical therapies, laser technologies, and personalized treatment approaches, offer patients safer, more effective, and tailored solutions with improved outcomes. With the development of innovative delivery systems and energy-based devices, patients can expect faster results and minimal downtime, enhancing their overall treatment experience. Additionally, the rise of combination therapies, which combine multiple treatment modalities to target different aspects of pigmentation disorders, provides patients with comprehensive solutions that address their unique skin concerns. As research and innovation continue, the demand for pigmentation disorder treatments will rise during the forecast period.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global pigmentation disorder treatment market, with a 43% market revenue share in 2023.

The region has a highly developed healthcare system with state-of-the-art medical facilities, research institutions, and dermatology clinics, providing an ideal environment for innovation and new treatments. Patients in North America have access to a large pool of dermatologists, plastic surgeons, and skincare experts specializing in pigmentation disorders. These healthcare providers offer various treatment options tailored to individual needs, ensuring optimal patient care. The regulatory framework in North America sets stringent standards for the approval of dermatological treatments, ensuring the safety and efficacy of available therapies. High levels of patient demand driven by awareness about skincare and beauty standards also contribute to the region's dominance in the market.

North America Region Pigmentation Disorder Treatment Market Share in 2023 - 43%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • Opzelura is the first topical JAK inhibitor cream approved by the US Food and Drug Administration to treat vitiligo in adults 12 and older.
Disorder Type Segment Analysis

The disorder type segment is divided into vitiligo, melasma and others. The vitiligo segment dominated the market, with a market share of around 42% in 2023. Vitiligo is a chronic skin condition characterized by the loss of pigment-producing cells, resulting in white patches on the skin. Its visibility on exposed areas of the body, such as the face and hands, often leads to significant psychological distress for affected individuals, motivating them to seek treatment to improve their appearance and self-confidence. The prevalence of vitiligo and its impact on patient's quality of life has spurred significant research efforts, developing novel treatment modalities and improvements in existing therapies. This ongoing research and innovation offer more effective and personalized treatment strategies for vitiligo patients. Increased awareness about vitiligo has also contributed to a greater understanding of the condition and its treatments.

  • In a deal valued at up to $1.36 billion, Incyte, a biopharmaceutical company based in Wilmington, agreed to buy a North Carolina-based company developing a novel therapy for vitiligo, a skin pigmentation condition.
Treatment Segment Analysis

The treatment segment is divided into corticosteroids, calcineurin inhibitors, and others. The Corticosteroids segment dominated the market, with a market share of around 45% in 2023. Corticosteroids are synthetic drugs that mimic the hormones produced by the adrenal glands. Corticosteroids are widely used to treat pigmentation disorders due to their anti-inflammatory and immunosuppressive properties. Preferred for their effectiveness and versatility, corticosteroids are popular for treating pigmentation disorders like hyperpigmentation and vitiligo. They reduce inflammation, common in these conditions, and suppress the immune response, particularly beneficial for autoimmune-mediated disorders like vitiligo. Corticosteroids are available in various formulations, including creams, ointments, lotions, gels, and solutions, making them easy to apply and suitable for different skin types and conditions. One of the key advantages of corticosteroids is their relatively fast results, often noticeable within a few weeks of starting treatment. This rapid response and their cost-effectiveness make them accessible to a wide range of patients seeking relief from pigmentation concerns.

  • For those suffering from Riehl's melanosis, an incurable acquired pigmentary illness, a hopeful new treatment has emerged. Due to inadequate treatment and the absence of a permanent cure, it has been regarded as an incurable pigmentary disease. Nonetheless, a group under the direction of Professor Park Young-jun of the Ajou University Hospital's Department of Dermatology discovered that Riehl's melanosis can be successfully treated using a combination of pico- and pulsed-dye lasers.
Distribution Channel Segment Analysis

The distribution channel segment is divided into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment dominated the market, with a market share of around 40% in 2023. Retail pharmacies are establishments where medications and healthcare products are dispensed directly to consumers. Retail pharmacies provide accessibility to pigmentation disorder treatments. Patients can easily obtain over-the-counter medications for mild pigmentation concerns without a prescription, making it convenient to address minor skin issues. Pharmacists at retail pharmacies play an essential role in patient education. They offer guidance on selecting appropriate treatments, provide information about proper usage and potential side effects, and address patients' questions or concerns. This education empowers patients to make informed decisions.

Some of the Key Market Players:
  • Arcutis Biotherapeutics
  • Astellas Pharma Inc.
  • Bausch Health Companies Inc
  • Dermavant Science Inc.
  • Dr Reddy's Laboratories Limited
  • Galderma SA
  • Glenmark Pharmaceuticals Limited
  • Incyte Corporation
  • Obagi Cosmeceuticals LLC
  • Viatirs Inc.

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2023 USD 7 Billion
Market size value in 2033 USD 11.40 Billion
CAGR (2024 to 2033) 5%
Historical data 2020-2022
Base Year 2023
Forecast 2024-2033
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East and Africa. Furthermore, the regions are further analyzed at the country level.
Segments Disorder Type, Treatment and Distribution Channel

Frequesntly Asked Questions

As per The Brainy Insights, the size of the global pigmentation disorder treatment market was valued at USD 7 billion in 2023 to USD 11.40 billion by 2033.

Global pigmentation disorder treatment market is growing at a CAGR of 5% during the forecast period 2024-2033.

The market's growth will be influenced by the rising awareness about pigmentation disorders and their treatments.

The cost of pigmentation disorder treatments could hamper the market growth.

Request Table of Content

+1

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. The Brainy Insights has segmented the global pigmentation disorder treatment market based on below mentioned segments:

Global Pigmentation Disorder Treatment Market by Disorder Type:

  • Vitiligo
  • Melasma
  • Others

Global Pigmentation Disorder Treatment Market by Treatment:

  • Corticosteroids
  • Calcineurin Inhibitor
  • Others

Global Pigmentation Disorder Treatment Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Pigmentation Disorder Treatment Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date